By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX) Announces The Appointment Of Life Sciences Industry Veteran Russell Skibsted As Chief Financial Officer 11/18/2015 9:47:23 AM
BioTime (BTX) And Hepregen Form Ascendance Biotech To Address The In Vitro Cell Biology Market 11/6/2015 8:45:17 AM
LifeMap Sciences, A Subsidiary Of BioTime (BTX), And Lab7 Systems Announce Partnership And Launch Of Integrated NGS Analysis Solution 11/4/2015 10:43:52 AM
Adi Mohanty Joins Michael D. West, PhD, As Co-CEO Of BioTime (BTX) 10/19/2015 10:55:55 AM
BioTime (BTX)’s Subsidiary OncoCyte Corporation Files Form 10 Registration Statement For Planned Distribution 10/8/2015 11:53:12 AM
BioTime (BTX) Announces The Closing Of A $20 Million Direct Registered Offering; Demand Exceeds NIS 80 Million Offered 10/2/2015 10:26:15 AM
BioTime (BTX) Agrees To Sell $5.1 Million Of Equity 10/2/2015 10:20:14 AM
Heraeus Medical GmbH And BioTime (BTX) Subsidiary Orthocyte Corporation Enter Into Exclusive Worldwide Development And Licensing Agreements 9/30/2015 11:48:55 AM
BioTime (BTX) Agrees to Sell Up To $20.7 Million Of Common Shares 9/28/2015 2:03:32 PM
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Receives FDA Fast-Track Designation For Opregen For The Treatment Of The Dry Form Of Age-Related Macular Degeneration 9/28/2015 12:51:33 PM